23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping job losses. The company that made its name by providing saliva ...

Now, an alliance between Novartis and genetic testing specialist 23andMe is trying to encourage greater awareness of Lp(a) and improve testing rates. The pilot programme will see a confidential ...

When evaluating 23andMe's stock performance and future outlook, investors should consider short-term market trends and long-term growth potential. This analysis will dive into recent stock metrics ...

Anna Wojcicki, the CEO of DNA testing app 23andMe that was sold for $6billion, is trying to buy the company back for just $75million. The troubled company was worth billions six years ago but now ...

23andMe CEO Anne Wojcicki and New Mountain Capital have submitted a proposal to take the embattled genetic testing company private, according to a Friday filing with the U.S. Securities and ...

Anne Wo­j­ci­c­ki, the CEO of 23andMe, has sub­mit­ted a new of­fer to take the com­pa­ny pri­vate with pri­vate eq­ui­ty firm New Moun­tain Cap­i­tal months af­ter … ...

Anne Wojcicki, CEO of 23andMe, began her journey with a clear vision; to help people take ownership of their health and benefit from the human genome. Her revolutionary startup empowered people to, ...